Back to Journals » Cancer Management and Research » Volume 13
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,368 | Dovepress* | 3,999+ | 354 | 4,353 | |
PubMed Central* | 369 | 177 | 546 | ||
Totals | 4,368 | 531 | 4,899 | ||
*Since 14 September 2021 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar